<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.molecularcytogenetics.org/feeds/mostaccessed/journal?quantity=&amp;format=rss&amp;version=">
        <title>Molecular Cytogenetics - Most accessed articles</title>
        <link>http://www.molecularcytogenetics.org</link>
        <description>The most accessed research articles published by Molecular Cytogenetics</description>
        <dc:date>2012-01-29T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.molecularcytogenetics.org/content/5/1/2" />
                                <rdf:li rdf:resource="http://www.molecularcytogenetics.org/content/5/1/5" />
                                <rdf:li rdf:resource="http://www.molecularcytogenetics.org/content/4/1/22" />
                                <rdf:li rdf:resource="http://www.molecularcytogenetics.org/content/3/1/1" />
                                <rdf:li rdf:resource="http://www.molecularcytogenetics.org/content/5/1/3" />
                                <rdf:li rdf:resource="http://www.molecularcytogenetics.org/content/5/1/6" />
                                <rdf:li rdf:resource="http://www.molecularcytogenetics.org/content/5/1/9" />
                                <rdf:li rdf:resource="http://www.molecularcytogenetics.org/content/1/1/26" />
                                <rdf:li rdf:resource="http://www.molecularcytogenetics.org/content/5/1/1" />
                                <rdf:li rdf:resource="http://www.molecularcytogenetics.org/content/5/1/8" />
                            </rdf:Seq>
        </items>
                 <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.molecularcytogenetics.org/content/5/1/2">
        <title>Isochromosome 13 in a patient with
childhood-onset schizophrenia, ADHD, and motor tic disorder
</title>
        <description>Background:
A small percentage of all cases of schizophrenia have a childhood onset. The impact on the individual and family can be devastating.  We report the results of genetic analyses from a patient with onset of visual hallucinations at 5 years, and a subsequent diagnosis at 9 years of schizophrenia, attention deficit hyperactivity disorder (ADHD) with hyperactivity and impulsivity, and chronic motor tic disorder.
Results:
Karyotypic analysis found 45,XX,i(13)(q10) in all cells examined.  Alpha satellite FISH of isochromosome 13 revealed a large unsplit centromeric region, interpreted as two centromeres separated by minimal or undetectable short-arm material or as a single monocentric centromere, indicating that the isochromosome likely formed post-zygotically by a short arm U-type or centromeric exchange.  Characterization of chromosome 13 simple tandem repeats and Affymetrix whole-genome 6.0 SNP array hybridization found homozygosity for all markers, and the presence of only a single paternal allele in informative markers, consistent with an isodisomic isochromosome of paternal origin.  Analysis of two chromosome 13 schizophrenia candidate genes, D-amino acid oxidase activator (DAOA) and 5-hydroxytryptamine (serotonin) receptor 2A (5-HTR2A), failed to identify non-synonymous coding mutations but did identify homozygous risk polymorphisms.
Conclusions:
We report a female patient with childhood-onset schizophrenia, ADHD, and motor tic disorder associated with an isodisomic isochromosome 13 of paternal origin and a 45,XX,i(13)(q10q10) karyotype.   We examined two potential mechanisms to explain chromosome 13 involvement in the patient&apos;s pathology, including reduction to homozygosity of a paternal mutation and reduction to homozygosity of a paternal copy number variation, but were unable to identify any overtly pathogenic abnormality.  Future studies may consider whether epigenetic mechanisms resulting from uniparental disomy (UPD) and the lack of chromosome 13 maternal alleles lead to the patient&apos;s features.</description>
        <link>http://www.molecularcytogenetics.org/content/5/1/2</link>
                <dc:creator>Sharon Graw</dc:creator>
                <dc:creator>Karen Swisshelm</dc:creator>
                <dc:creator>Kirsten Floyd</dc:creator>
                <dc:creator>Billie Carstens</dc:creator>
                <dc:creator>Marianne Wamboldt</dc:creator>
                <dc:creator>Randall Ross</dc:creator>
                <dc:creator>Sherry Leonard</dc:creator>
                <dc:source>Molecular Cytogenetics 2012, null:2</dc:source>
        <dc:date>2012-01-03T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1755-8166-5-2</dc:identifier>
                                <prism:require>/content/figures/1755-8166-5-2-toc.gif</prism:require>
                <prism:publicationName>Molecular Cytogenetics</prism:publicationName>
        <prism:issn>1755-8166</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>2</prism:startingPage>
        <prism:publicationDate>2012-01-03T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.molecularcytogenetics.org/content/5/1/5">
        <title>Marfan syndrome with a complex chromosomal rearrangement including deletion of the FBN1 gene.</title>
        <description>Background:
The majority of Marfan syndrome (MFS) cases is caused by mutations in the fibrillin-1 gene (FBN1), mapped to chromosome 15q21.1. Only few reports on deletions including the whole FBN1 gene, detected by molecular cytogenetic techniques, were found in literature. Results: We report here on a female patient with clinical symptoms of the MFS spectrum plus craniostenosis, hypothyroidism and intellectual deficiency who presents a 1.9 Mb deletion, including the FBN1 gene and a complex rearrangement with eight breakpoints involving chromosomes 6, 12 and 15. Discussion: This is the first report of MFS with a complex chromosome rearrangement involving a deletion of FBN1 and contiguous genes. In addition to the typical clinical findings of the Marfan syndrome due to FBN1 gene haploinsufficiency, the patient presents features which may be due to the other gene deletions and possibly to the complex chromosome rearrangement.</description>
        <link>http://www.molecularcytogenetics.org/content/5/1/5</link>
                <dc:creator>Mileny Colovati</dc:creator>
                <dc:creator>Luciana da Silva</dc:creator>
                <dc:creator>Sylvia Takeno</dc:creator>
                <dc:creator>Tatiane Mancini</dc:creator>
                <dc:creator>Ana R Dutra</dc:creator>
                <dc:creator>Roberta Guilherme</dc:creator>
                <dc:creator>Claudia de Mello</dc:creator>
                <dc:creator>Maria I Melaragno</dc:creator>
                <dc:creator>Ana B Perez</dc:creator>
                <dc:source>Molecular Cytogenetics 2012, null:5</dc:source>
        <dc:date>2012-01-19T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1755-8166-5-5</dc:identifier>
                                <prism:require>/content/figures/1755-8166-5-5-toc.gif</prism:require>
                <prism:publicationName>Molecular Cytogenetics</prism:publicationName>
        <prism:issn>1755-8166</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>5</prism:startingPage>
        <prism:publicationDate>2012-01-19T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.molecularcytogenetics.org/content/4/1/22">
        <title>The genome diversity and karyotype evolution of mammals</title>
        <description>The past decade has witnessed an explosion of genome sequencing and mapping in evolutionary diverse species. While full genome sequencing of mammals is rapidly progressing, the ability to assemble and align orthologous whole chromosome regions from more than a few species is still not possible. The intense focus on building of comparative maps for companion (dog and cat), laboratory (mice and rat) and agricultural (cattle, pig, and horse) animals has traditionally been used as a means to understand the underlying basis of disease-related or economically important phenotypes. However, these maps also provide an unprecedented opportunity to use multispecies analysis as a tool for inferring karyotype evolution. Comparative chromosome painting and related techniques are now considered to be the most powerful approaches in comparative genome studies. Homologies can be identified with high accuracy using molecularly defined DNA probes for fluorescence in situ hybridization (FISH) on chromosomes of different species. Chromosome painting data are now available for members of nearly all mammalian orders. In most orders, there are species with rates of chromosome evolution that can be considered as &apos;default&apos; rates. The number of rearrangements that have become fixed in evolutionary history seems comparatively low, bearing in mind the 180 million years of the mammalian radiation. Comparative chromosome maps record the history of karyotype changes that have occurred during evolution. The aim of this review is to provide an overview of these recent advances in our endeavor to decipher the karyotype evolution of mammals by integrating the published results together with some of our latest unpublished results.</description>
        <link>http://www.molecularcytogenetics.org/content/4/1/22</link>
                <dc:creator>Alexander Graphodatsky</dc:creator>
                <dc:creator>Vladimir Trifonov</dc:creator>
                <dc:creator>Roscoe Stanyon</dc:creator>
                <dc:source>Molecular Cytogenetics 2011, null:22</dc:source>
        <dc:date>2011-10-12T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1755-8166-4-22</dc:identifier>
                                <prism:require>/content/figures/1755-8166-4-22-toc.gif</prism:require>
                <prism:publicationName>Molecular Cytogenetics</prism:publicationName>
        <prism:issn>1755-8166</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>22</prism:startingPage>
        <prism:publicationDate>2011-10-12T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.molecularcytogenetics.org/content/3/1/1">
        <title>Human interphase chromosomes: a review of available molecular cytogenetic technologies</title>
        <description>Human karyotype is usually studied by classical cytogenetic (banding) techniques. To perform it, one has to obtain metaphase chromosomes of mitotic cells. This leads to the impossibility of analyzing all the cell types, to moderate cell scoring, and to the extrapolation of cytogenetic data retrieved from a couple of tens of mitotic cells to the whole organism, suggesting that all the remaining cells possess these genomes. However, this is far from being the case inasmuch as chromosome abnormalities can occur in any cell along ontogeny. Since somatic cells of eukaryotes are more likely to be in interphase, the solution of the problem concerning studying postmitotic cells and larger cell populations is interphase cytogenetics, which has become more or less applicable for specific biomedical tasks due to achievements in molecular cytogenetics (i.e. developments of fluorescence in situ hybridization -- FISH, and multicolor banding -- MCB). Numerous interphase molecular cytogenetic approaches are restricted to studying specific genomic loci (regions) being, however, useful for identification of chromosome abnormalities (aneuploidy, polyploidy, deletions, inversions, duplications, translocations). Moreover, these techniques are the unique possibility to establish biological role and patterns of nuclear genome organization at suprachromosomal level in a given cell. Here, it is to note that this issue is incompletely worked out due to technical limitations. Nonetheless, a number of state-of-the-art molecular cytogenetic techniques (i.e multicolor interphase FISH or interpahase chromosome-specific MCB) allow visualization of interphase chromosomes in their integrity at molecular resolutions. Thus, regardless numerous difficulties encountered during studying human interphase chromosomes, molecular cytogenetics does provide for high-resolution single-cell analysis of genome organization, structure and behavior at all stages of cell cycle.</description>
        <link>http://www.molecularcytogenetics.org/content/3/1/1</link>
                <dc:creator>Svetlana Vorsanova</dc:creator>
                <dc:creator>Yuri Yurov</dc:creator>
                <dc:creator>Ivan Iourov</dc:creator>
                <dc:source>Molecular Cytogenetics 2010, null:1</dc:source>
        <dc:date>2010-01-11T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1755-8166-3-1</dc:identifier>
                                <prism:require>/content/figures/1755-8166-3-1-toc.gif</prism:require>
                <prism:publicationName>Molecular Cytogenetics</prism:publicationName>
        <prism:issn>1755-8166</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>1</prism:startingPage>
        <prism:publicationDate>2010-01-11T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.molecularcytogenetics.org/content/5/1/3">
        <title>Spectral Karyotyping for Identification of Constitutional Chromosomal Abnormalities at a National Reference Laboratory  </title>
        <description>Spectral karyotyping is a diagnostic tool that allows visualization of chromosomes in different colors using the FISH technology and a spectral imaging system. To assess the value of spectral karyotyping analysis for identifying constitutional supernumerary marker chromosomes or derivative chromosomes at a national reference laboratory, we reviewed the results of 179 consecutive clinical samples (31 prenatal and 148 postnatal) submitted for spectral karyotyping. Over 90% of the cases were requested to identify either small supernumerary marker chromosomes (sSMCs) or chromosomal exchange material detected by G-banded chromosome analysis. We also reviewed clinical indications of those cases with marker chromosomes in which chromosomal origin was identified by spectral karyotyping. Our results showed that spectral karyotyping identified the chromosomal origin of marker chromosomes or the source of derivative chromosomal material in 158 (88%) of the 179 clinical cases; the identification rate was slightly higher for postnatal (89%) compared to prenatal (84%) cases. Cases in which the origin could not be identified had either a small marker chromosome present at a very low level of mosaicism (&lt;10%), or contained very little euchromatic material. Supplemental FISH analysis confirmed the spectral karyotyping results in all 158 cases. Clinical indications for prenatal cases were mainly for marker identification after amniocentesis. For postnatal cases, the primary indications were developmental delay and multiple congenital anomalies (MCA). The most frequently encountered markers were of chromosome 15 origin for satellited chromosomes, and chromosomes 2 and 16 for non-satellited chromosomes. We were able to obtain pertinent clinical information for 47% (41/88) of cases with an identified abnormal chromosome. We conclude that spectral karyotyping is sufficiently reliable for use and provides a valuable diagnostic tool for establishing the origin of supernumerary marker chromosomes or derivative chromosomal material that cannot be identified with standard cytogenetic techniques.</description>
        <link>http://www.molecularcytogenetics.org/content/5/1/3</link>
                <dc:creator>Arturo Anguiano</dc:creator>
                <dc:creator>Boris Wang</dc:creator>
                <dc:creator>Shirong Wang</dc:creator>
                <dc:creator>Fatih Boyar</dc:creator>
                <dc:creator>Loretta Mahon</dc:creator>
                <dc:creator>Mohamed El Naggar</dc:creator>
                <dc:creator>Peter Kohn</dc:creator>
                <dc:creator>Mary Haddadin</dc:creator>
                <dc:creator>Vladimira Sulcova</dc:creator>
                <dc:creator>Adam Sbeiti</dc:creator>
                <dc:creator>Mervat Ayad</dc:creator>
                <dc:creator>Beverly White</dc:creator>
                <dc:creator>Charles Strom</dc:creator>
                <dc:source>Molecular Cytogenetics 2012, null:3</dc:source>
        <dc:date>2012-01-16T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1755-8166-5-3</dc:identifier>
                                <prism:require>/content/figures/1755-8166-5-3-toc.gif</prism:require>
                <prism:publicationName>Molecular Cytogenetics</prism:publicationName>
        <prism:issn>1755-8166</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>3</prism:startingPage>
        <prism:publicationDate>2012-01-16T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.molecularcytogenetics.org/content/5/1/6">
        <title>A recurrent translocation is mediated by homologous recombination between HERV-H elements</title>
        <description>Background:
Chromosome rearrangements are caused by many mutational mechanisms; of these, recurrent rearrangements can be particularly informative for teasing apart DNA sequence-specific factors. Some recurrent translocations are mediated by homologous recombination between large blocks of segmental duplications on different chromosomes. Here we describe a recurrent unbalanced translocation casued by recombination between shorter homologous regions on chromosomes 4 and 18 in two unrelated children with intellectual disability.
Results:
Array CGH resolved the breakpoints of the 6.97-Megabase (Mb) loss of 18q and the 7.30-Mb gain of 4q. Sequencing across the translocation breakpoints revealed that both translocations occurred between 92%-identical human endogenous retrovirus (HERV) elements in the same orientation on chromosomes 4 and 18. In addition, we find sequence variation in the chromosome 4 HERV that makes one allele more like the chromosome 18 HERV.
Conclusions:
Homologous recombination between HERVs on the same chromosome is known to cause chromosome deletions, but this is the first report of interchromosomal HERV-HERV recombination leading to a translocation. It is possible that normal sequence variation in substrates of non-allelic homologous recombination (NAHR) affects the alignment of recombining segments and influences the propensity to chromosome rearrangement.</description>
        <link>http://www.molecularcytogenetics.org/content/5/1/6</link>
                <dc:creator>Karen Hermetz</dc:creator>
                <dc:creator>Urvashi Surti</dc:creator>
                <dc:creator>Jannine Cody</dc:creator>
                <dc:creator>M. Katharine Rudd</dc:creator>
                <dc:source>Molecular Cytogenetics 2012, null:6</dc:source>
        <dc:date>2012-01-19T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1755-8166-5-6</dc:identifier>
                                <prism:require>/content/figures/1755-8166-5-6-toc.gif</prism:require>
                <prism:publicationName>Molecular Cytogenetics</prism:publicationName>
        <prism:issn>1755-8166</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>6</prism:startingPage>
        <prism:publicationDate>2012-01-19T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.molecularcytogenetics.org/content/5/1/9">
        <title>&quot;Familial&quot; versus &quot;Sporadic&quot; Intellectual Disability: Contribution of Common Microdeletion and Microduplication Syndromes</title>
        <description>Background:
Interstitial Microdeletion and Microduplication syndromes have been proposed as a significant cause of sporadic intellectual disability (ID) but the role of such aberrations in familial ID has not yet been investigated. As the balanced chromosomal abnormalities commonly lead to the recurrent ID or multiple congenital anomalies, this study was designed to evaluate whether it was justified to investigate such aberrations in familial ID patients. Three hundred and twenty eight patients from 101 unrelated Iranian families with more than two ID patients in the first-degree relatives, have been investigated. Assessment of a panel of 21 common Microdeletion and Microduplication syndromes (CMMS) was carried out using Multiplex Ligation-Dependent Probe Amplification (MLPA) technique.
Results:
Among the families studied, 27.7% had 4-12, 35.6% had 3 and 36.6% had 2 affected individuals in the first-degree relatives. An autosomal dominant inheritance of Williams-Beuren syndrome (WBS) was detected in a family with no clinical suspicion of WBS. The prevalence of CMMS was therefore,0.99%.
Conclusion:
This is the first investigation of a panel of CMMS in a large sample set of &quot;familial ID patients&quot;. The findings of this study showed the low prevalence of CMMSs in &quot;familial ID&quot; patients in spite of the significant contribution of such aberrations in &quot;sporadic ID&quot; which has a very useful practical impact by avoiding unnecessary diagnostic tests in &quot;familial ID&quot; patients.</description>
        <link>http://www.molecularcytogenetics.org/content/5/1/9</link>
                <dc:creator>Maryam Rafati</dc:creator>
                <dc:creator>Elaheh Seyyedaboutorabi</dc:creator>
                <dc:creator>Mohammad Ghadirzadeh</dc:creator>
                <dc:creator>Yaser Heshmati</dc:creator>
                <dc:creator>Homeira Adibi</dc:creator>
                <dc:creator>Zarrintaj Keihandoust</dc:creator>
                <dc:creator>Mohammad Eshraghian</dc:creator>
                <dc:creator>Gholam Javadi</dc:creator>
                <dc:creator>Jila Dastan</dc:creator>
                <dc:creator>Alireza Mosavi-Jarrahi</dc:creator>
                <dc:creator>Azadeh Hoseini</dc:creator>
                <dc:creator>Marzieh Purhoseini</dc:creator>
                <dc:creator>Saeed Ghaffari</dc:creator>
                <dc:source>Molecular Cytogenetics 2012, null:9</dc:source>
        <dc:date>2012-01-29T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1755-8166-5-9</dc:identifier>
                                <prism:require>/content/figures/1755-8166-5-9-toc.gif</prism:require>
                <prism:publicationName>Molecular Cytogenetics</prism:publicationName>
        <prism:issn>1755-8166</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>9</prism:startingPage>
        <prism:publicationDate>2012-01-29T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.molecularcytogenetics.org/content/1/1/26">
        <title>Chromosomal mosaicism goes global</title>
        <description>Intercellular differences of chromosomal content in the same individual are defined as chromosomal mosaicism (alias intercellular or somatic genomic variations or, in a number of publications, mosaic aneuploidy). It has long been suggested that this phenomenon poorly contributes both to intercellular (interindividual) diversity and to human disease. However, our views have recently become to change due to a series of communications demonstrated a higher incidence of chromosomal mosaicism in diseased individuals (major psychiatric disorders and autoimmune diseases) as well as depicted chromosomal mosaicism contribution to genetic diversity, the central nervous system development, and aging. The later has been produced by significant achievements in the field of molecular cytogenetics. Recently, Molecular Cytogenetics has published an article by Maj Hulten and colleagues that has provided evidences for chromosomal mosaicism to underlie formation of germline aneuploidy in human female gametes using trisomy 21 (Down syndrome) as a model. Since meiotic aneuploidy is suggested to be the leading genetic cause of human prenatal mortality and postnatal morbidity, these data together with previous findings define chromosomal mosaicism not as a casual finding during cytogenetic analyses but as a more significant biological phenomenon than previously recognized. Finally, the significance of chromosomal mosaicism can be drawn from the fact, that this phenomenon is involved in genetic diversity, normal and abnormal prenatal development, human diseases, aging, and meiotic aneuploidy, the intrinsic cause of which remains, as yet, unknown.</description>
        <link>http://www.molecularcytogenetics.org/content/1/1/26</link>
                <dc:creator>Ivan Iourov</dc:creator>
                <dc:creator>Svetlana Vorsanova</dc:creator>
                <dc:creator>Yuri Yurov</dc:creator>
                <dc:source>Molecular Cytogenetics 2008, null:26</dc:source>
        <dc:date>2008-11-25T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1755-8166-1-26</dc:identifier>
                                <prism:require>/content/figures/1755-8166-1-26-toc.gif</prism:require>
                <prism:publicationName>Molecular Cytogenetics</prism:publicationName>
        <prism:issn>1755-8166</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>26</prism:startingPage>
        <prism:publicationDate>2008-11-25T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.molecularcytogenetics.org/content/5/1/1">
        <title>A novel deletion in 2q24.1q24.2 in a girl with mental retardation and  generalized hypotonia: a case report</title>
        <description>Background:
Chromosomal imbalances, recognized as the major cause of mental retardation, are often due to submicroscopic deletions or duplications not evidenced by conventional cytogenetic methods. To date, interstitial deletion of long arm of chromosome 2 have been reported for more than 100 cases, although studies reporting small interstitial deletions involving the 2q24.1q24.2 region are rare. With the widespread clinical use of comparative genomic hybridization chromosomal microarray technology, several cryptic chromosome imbalances have outlined new genotype-phenotype correlations and isolated a number of distinctive clinical conditions.
Results:
here we report on a girl with mental retardation and generalized hypotonia. A genome-wide screen for copy number variations (CNVs) using single nucleotide polymorphisms (SNPs) array revealed a 7.5 Mb interstitial deletion of chromosome region 2q24.1q24.2 encompassing 59 genes, which was absent in parents. The gene content analysis of the deleted region and review of the literature revealed the presence of some genes that may be indicated as good candidate in generating the main clinical features of the patient.Discussionthe present case represents a further patient described in the literature with an interstitial deletion of chromosome 2q24.1q24.2. Our patient shares some clinical features with the previously reported patients carriers of overlapping 2q24 deletion. Although more cases are needed to delineate the full-blown phenotype of 2q24.1q24.2 deletion syndrome, published data and present observation suggest that hemizygosity of this region results in a clinically recognizable phenotype. Considering these clinical and cytogenetic similarities, we suggest the existence of an emerging syndrome associated to 2q24.1q24.2 region.</description>
        <link>http://www.molecularcytogenetics.org/content/5/1/1</link>
                <dc:creator>Orazio Palumbo</dc:creator>
                <dc:creator>Pietro Palumbo</dc:creator>
                <dc:creator>Teresa Palladino</dc:creator>
                <dc:creator>Raffaella Stallone</dc:creator>
                <dc:creator>Leopoldo Zelante</dc:creator>
                <dc:creator>Massimo Carella</dc:creator>
                <dc:source>Molecular Cytogenetics 2012, null:1</dc:source>
        <dc:date>2012-01-03T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1755-8166-5-1</dc:identifier>
                                <prism:require>/content/figures/1755-8166-5-1-toc.gif</prism:require>
                <prism:publicationName>Molecular Cytogenetics</prism:publicationName>
        <prism:issn>1755-8166</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>1</prism:startingPage>
        <prism:publicationDate>2012-01-03T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.molecularcytogenetics.org/content/5/1/8">
        <title>Prenatal diagnosis of a trisomy 7/trisomy 13 mosaicism.</title>
        <description>Double aneuploidy mosaicism of two different aneuploidy cell lines is a rare event. We describe for the first time a double trisomy mosaicism, involving chromosomes 7 and 13 in a fetus presenting with multiple congenital anomalies. No evidence for chimerism was found by DNA genotyping. The origin of both trisomies are consistent with isodisomy of maternal origin. Therefore, it is most likely that the double trisomy mosaicism arose from two independent events very early in embryonic development. The trisomy 7 and 13 cells were shown to be of maternal origin.</description>
        <link>http://www.molecularcytogenetics.org/content/5/1/8</link>
                <dc:creator>Karin Huijsdens-van Amsterdam</dc:creator>
                <dc:creator>Daniela Barge-Schaapveld</dc:creator>
                <dc:creator>Inge Mathijssen</dc:creator>
                <dc:creator>Marielle Alders</dc:creator>
                <dc:creator>Eva Pajkrt</dc:creator>
                <dc:creator>Alida Knegt</dc:creator>
                <dc:source>Molecular Cytogenetics 2012, null:8</dc:source>
        <dc:date>2012-01-27T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1755-8166-5-8</dc:identifier>
                                <prism:require>/content/figures/1755-8166-5-8-toc.gif</prism:require>
                <prism:publicationName>Molecular Cytogenetics</prism:publicationName>
        <prism:issn>1755-8166</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>8</prism:startingPage>
        <prism:publicationDate>2012-01-27T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>

